Wegovy 1 mg

Wegovy 1 mg is a semaglutide solution for subcutaneous use, designed to support weight management. This prescription medication is manufactured by Novo Nordisk Canada Inc. and originates from Canada.

Wegovy 1 mg is primarily used as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Semaglutide, the active ingredient, is a glucagon-like peptide-1 (GLP-1) receptor agonist that may help regulate appetite and food intake. People often ask, 'What is Wegovy used for?' and the answer is typically related to weight management and supporting a healthier lifestyle.

Common effects of Wegovy 1 mg may include nausea, diarrhea, constipation, injection site reactions, and fatigue. These effects can vary from person to person and may subside as the body adjusts to the medication. It's important to monitor how your body responds to the treatment and consult with a healthcare provider if any effects are concerning.

Wegovy 1 mg should be handled with care, stored properly, and administered as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions to minimize potential risks. Always inform your healthcare provider about any pre-existing conditions or other medications you are taking before starting Wegovy.

Wegovy 1 mg may interact with other medications, including those that affect the stomach or intestines, as well as drugs metabolized by the liver. It is advisable to avoid alcohol while using this medication, as it may exacerbate certain side effects. Always consult with a healthcare provider to understand potential interactions and manage them appropriately.